AKT1 and neoplasm: Upon activation, EGFR initiates downstream signaling pathways, including the phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (AKT) and RAS/MEK/ERK pathways, to drive tumor survival, proliferation, angiogenesis, invasion, and metastasis [10, 11].